To include your compound in the COVID-19 Resource Center, submit it here.

Sebazole: Phase III data

In a double-blind, vehicle-controlled, U.S. Phase III trial in 459 patients,

Read the full 110 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE